Dr LISA WOODHOUSE L.Woodhouse@nottingham.ac.uk
RESEARCH FELLOW
Characteristics and outcomes of patients with or without a bleeding event: results from the triple antiplatelets for reducing dependency in ischaemic stroke (TARDIS) trial
Woodhouse, Lisa J.; Flaherty, Katie; Appleton, Jason P.; Sprigg, Nikola; Bath, Philip M.W.
Authors
Katie Flaherty
Jason P. Appleton
Professor NIKOLA SPRIGG nikola.sprigg@nottingham.ac.uk
PROFESSOR OF STROKE MEDICINE
Professor PHILIP BATH philip.bath@nottingham.ac.uk
STROKE ASSOCIATION PROFESSOR OF STROKE MEDICINE
Abstract
Background: Several studies showed that hyperglycaemia is associated with poorer prognosis in intracerebral haemorrhage. We explored the characteristics and outcomes of patients with hyperglycaemia in the Tranexamic acid in IntraCerebral Haemorrhage-2 (TICH-2) trial.
Methods: Of the 2325 patients recruited, 2028 with available baseline glucose levels were included for analysis. Baseline characteristics, radiological and clinical outcomes were compared between patients with admission glucose levels of <7.8 and ≥7.8 mmol/L (hyperglycaemia).
Results: 545 (26.9%) patients had hyperglycaemia and did not differ from normoglycaemic patients in age (69.3 years vs 68.7 years) and sex (female: 246, 45.1% vs 641, 43.2%). Hyperglycaemic patients were more likely to be diabetic (187, 34.3% vs 94, 6.3%), have worse NIHSS (13.8 ± 7.7 vs 12.1 ± 7.1), larger baseline haematoma (30.2 ± 31.5 mL vs 21.2 ± 24.3 mL) and perihaematomal oedema volumes (15.8 ± 18.1 mL vs 11.7 ± 14.1 mL). There were no significant differences in haematoma expansion and increase in oedema volume between the two groups (table). Hyperglycaemia did not increase the risk of death or worse modified Rankin Scale at day 90 after adjusting for covariates including baseline haematoma volume.
Discussion: Hyperglycaemia was associated with larger haematomas and more severe stroke on admission but did not result in worse outcomes after accounting for baseline haematoma volume.
Citation
Woodhouse, L. J., Flaherty, K., Appleton, J. P., Sprigg, N., & Bath, P. M. Characteristics and outcomes of patients with or without a bleeding event: results from the triple antiplatelets for reducing dependency in ischaemic stroke (TARDIS) trial. Presented at 4th European Stroke Organisation Conference (ESOC 2018)
Conference Name | 4th European Stroke Organisation Conference (ESOC 2018) |
---|---|
End Date | May 18, 2018 |
Acceptance Date | Feb 25, 2018 |
Publication Date | May 16, 2018 |
Deposit Date | Mar 28, 2018 |
Publicly Available Date | May 16, 2018 |
Peer Reviewed | Peer Reviewed |
Public URL | https://nottingham-repository.worktribe.com/output/932595 |
Contract Date | Mar 28, 2018 |
Files
TARDIS ESOC 2018 Bleeding characteristics abstract 201801191.pdf
(66 Kb)
PDF
You might also like
Influence of Time to Achieve Target Systolic Blood Pressure on Outcome after Intracerebral Hemorrhage: The Blood Pressure in Acute Stroke Collaboration
(2024)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search